Literature DB >> 1001353

Comparison of the pharmacokinetics of intravenous dl-propranolol in borderline and permanent hypertension.

Y A Weiss, M E Safar, C Chevillard, A Frydman, A Simon, P Lemaire, J M Alexandre.   

Abstract

In borderline and permanent hypertensives after rapid i.v. injection of dl-propranolol 0.2 mg/kg plasma levels were measured and were fitted to a two-compartment open-model. In borderline patients, characterized by a high basal cardiac output (CO), plasma levels were always lower than in permanent hypertensives. The biological half-life was reduced and the central volume of distribution, volume of distribution at pseudo-equilibrium and total clearance (TC) were markedly increased. In the overall population, there was a significant positive correlation between CO and TC. Rapid achievement of a predetermined plateau in each group constituted experimental proof of the validity of the two-compartment open-model for kinetic analysis of propranolol i.v. If kinetic parameters from permanent hypertensive were applied to borderline hypertensives a lower plateau was obtained. Thus, in so far as beta-blockade is related to plasma level of propranolol, an increased intravenous dose may be required in patients with high CO.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1001353     DOI: 10.1007/bf00563074

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  20 in total

1.  Pharmacokinetics of oral propranolol in chronic renal disease.

Authors:  D T Lowenthal; W A Briggs; T P Gibson; H Nelson; W J Cirksena
Journal:  Clin Pharmacol Ther       Date:  1974-11       Impact factor: 6.875

2.  Hemodynamic findings in human arterial hypertension.

Authors:  M Safar; P Milliez
Journal:  Rev Eur Etud Clin Biol       Date:  1972-02

3.  Rapidly achieved plasma concentration plateaus, with observations on theophylline kinetics.

Authors:  P A Mitenko; R I Ogilvie
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

4.  The almost complete hepatic extraction of propranolol during intravenous administration in the dog.

Authors:  D G Shand; G H Evans; A S Nies
Journal:  Life Sci I       Date:  1971-12-15

5.  Hemodynamic studies in patients with borderline blood pressure elevation.

Authors:  S Julius; J Conway
Journal:  Circulation       Date:  1968-08       Impact factor: 29.690

6.  Plasma propranolol levels in adults with observations in four children.

Authors:  D G Shand; E M Nuckolls; J A Oates
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

7.  Physiological and clinical aspects of beta adrenergic blockade.

Authors:  S Wolfson; R Gorlin
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

8.  Increase in hepatic blood flow and d-propranolol clearance by glucagon in the monkey.

Authors:  R A Branch; D G Shand; A S Nies
Journal:  J Pharmacol Exp Ther       Date:  1973-12       Impact factor: 4.030

9.  Regional hemodynamic effects of beta-adrenergic blockade with propranolol in the unanesthetized primate.

Authors:  A S Nies; G H Evans; D G Shand
Journal:  Am Heart J       Date:  1973-01       Impact factor: 4.749

10.  Treatment of hypertension with propranolol.

Authors:  B N Prichard; P M Gillam
Journal:  Br Med J       Date:  1969-01-04
View more
  6 in total

1.  Modelling of initial distribution of drugs following intravenous bolus injection.

Authors:  M Weiss
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

2.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

3.  (+)-Propranolol clearance, an estimation of hepatic blood flow in man.

Authors:  Y A Weiss; M E Safar; J P Lehner; J A Levenson; A Simon; J M Alexandre
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

4.  Clinical pharmacokinetics of buffered propranolol sublingual tablet (Promptol™)-application of a new "physiologically based" model to assess absorption and disposition.

Authors:  Yanfeng Wang; Zhijun Wang; Zhong Zuo; Brian Tomlinson; Benjamin T K Lee; Michael B Bolger; Moses S S Chow
Journal:  AAPS J       Date:  2013-04-19       Impact factor: 4.009

5.  Pharmacokinetics of propranolol.

Authors:  L Borgström; C G Johansson; H Larsson; R Lenander
Journal:  J Pharmacokinet Biopharm       Date:  1981-08

6.  Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.

Authors:  Josée Bouchard; Greene Shepherd; Robert S Hoffman; Sophie Gosselin; Darren M Roberts; Yi Li; Thomas D Nolin; Valéry Lavergne; Marc Ghannoum
Journal:  Crit Care       Date:  2021-06-10       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.